Researchers are developing liquid nanoparticles to bypass the barriers posed by thick mucus and frequent infections in cystic fibrosis lungs and prevent antimicrobial resistance.
The drug candidate utilizes a lipid-mediated aerosolized platform to deliver CFTR messenger RNA to the lungs.
Clinicians share best practices for implementing CFTR modulators in some of their youngest patients, while research explores their potential to lessen the burden of care.
This independent, randomized study compared available HFCWO vests in order to assess patient preference and perceived efficacy in several key categories.
Read More
Recipharm’s Vowst therapy is approved to prevent reinfection of C. difficile, which can infect patients with cystic fibrosis and other chronic diseases.
Read More
The medication now is approved for use in children with cystic fibrosis ages 1 month to less than 4 months old who have at least one mutation in their cystic fibrosis transmembrane conductance regulator gene.
Read More
The new guide can assist providers in learning and practicing skills to prevent or manage respiratory symptoms in patients with chronic lung disease.
Read More
Researchers discovered a new cell state in embryonic airway development—overlooked until now—that they say may pave the way for new approaches to treating chronic respiratory diseases.
Read More
BiomX has announced positive data from a study assessing the safety and tolerability of BX004 in nine cystic patients.
Read More
The funding will allow Aluna to continue growing its respiratory management platform among doctors and patients managing asthma, cystic fibrosis, and COPD.
Read More
The American Lung Association has launched its Patient & Caregiver Network to support over 34 million Americans diagnosed with COPD, asthma, and other lung diseases.
Read More
Researchers compared airway clearance interventions in cystic fibrosis patients using specific cough technique (SCT) and forced expiration technique (FET).
Read More
MUC5AC, an airway protein, plays an important (and overlooked) role in the body’s mucociliary clearance system, according to research published in Science Advances.
Read More
A newly-developed cystic fibrosis urine test can make it much easier for doctors to diagnose how badly a patient is affected by the hereditary diseases.
Read More
Enrollment has begun in an early-stage clinical trial evaluating phage therapy (bacteriophage) in adults with cystic fibrosis who carry Pseudomonas aeruginosa in their lungs.
Read More